Ind-Swift Laboratories Ltd. — Capital/Financing Update 2024

Apr 19, 2024

==> picture [425 x 83] intentionally omitted <==

Ref: ISLL:CH:2024

Date: 19[th] April, 2024

The President	The Vice President,
Corporate Relationship Department	Listing Compliance Department,
BSE Limited	National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers,	Exchange Plaza, 5th Floor
25th Floor, Dalal Street,	Plot No. C/2, G-Block,
Mumbai 400 001	Bandra Kurla Complex, Bandra (E),
	Mumbai 400 051

ISIN: INE915B01019, INE915B07024 BSE Scrip Code: 532305, 957989 NSE Symbol: INDSWFTLAB

SUBJECT: INTIMATION UNDER REGULATION 30 REGARDING INCORPORATION OF WHOLLY OWNED SUBSIDIARY

Dear Sir/Ma’am,

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (hereinafter “SEBI Listing Regulations”) read with Para A-Part A of Schedule III of the SEBI Listing Regulations, including any statutory modification(s), amendment(s) or re-enactment(s) thereof for the time being in force we hereby inform you that Ind-Swift Laboratories Limited has approved the incorporation of a wholly owned subsidiary(“WOS”) in Dubai, United Arab Emirates (UAE) in the name and style of “Ind-Swift (Dubai) Ltd.” or such other name as may be approved by the concerned authorities of the UAE.

The Company shall further intimate on receipt of Certificate of Incorporation as and when the same is received by the Company.

Further the details required under SEBI Master Circular issued vide circular no. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 and Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed herewith as Annexure I.

The above is for your information and records.

With Regards,

For IND-SWIFT LABORATORIES LTD.

Pardeep Digitally signed by Pardeep Verma Verma Date: 2024.04.19 10:46:31 +05'30' PARDEEP VERMA VP-CORPORATE AFFAIRS & COMPANY SECRETARY

==> picture [425 x 40] intentionally omitted <==

==> picture [425 x 83] intentionally omitted <==

Annexure I

==> picture [448 x 554] intentionally omitted <==

----- Start of picture text -----

S. No. Particulars Details
1. Name of the Target Company, details in brief such as Name: Ind-Swift (Dubai) Ltd. or
size, turnover, etc. such other name as may be approved
by the concerned authorities of the
UAE
size/Turnover: Not applicable (since
it is a new entity which is yet to be
incorporated)
2. Whether the acquisition would fall within related party The investment in the wholly owned
transaction(s) and whether the promoter/promoter group/ subsidiary would be a Related Party
group companies have any interest in the entity being Transaction. The investment shall be
acquired? If yes, nature of interest and details thereof and made on arms’ Length basis.
whether the same is done at “arm’s length”
3. Industry to which the entity being acquired belongs Pharmaceuticals
4. Objects and effects of acquisition (including but not The WOS intends to strategically
limited to, disclosure of reasons for acquisition of target invest in pharmaceutical and allied
entity, if its business is outside the main line of business activities. This includes exploring
of the listed entity) potential acquisitions, tie-ups, or
joint ventures. Additionally, the
Company aims to establish and
operate pharmaceutical
manufacturing units.
5. Brief details of any governmental or regulatory The WOS is proposed to be
approvals required for the acquisition; incorporated in Dubai and is subject
to regulatory approvals as per the
laws of Dubai.
6. Indicative time period for completion of the acquisition; NA
7. Nature of consideration - whether cash consideration or Subscription to 100% of the equity in
share swap and details of the same; WOS, to be paid in cash.
8. Cost of acquisition or the price at which the shares are NA
acquired
9. Percentage of shareholding / control acquired and / or 100%
number of shares acquired;
10. Brief background about the entity acquired in terms of Not Applicable since the company is
products / line of business acquired, date of yet to be incorporated.
incorporation, history of last 3 years turnover, country in
which the acquired entity has presence and any other
significant information (in brief)
----- End of picture text -----

Pardeep Digitally signed by Pardeep Verma Verma Date: 2024.04.19 10:47:04 +05'30'